Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brimonidine Implant for Visual Function in Macula-off Retinal Detachment
NCT00972374Phase 2Completed
- Sponsor
- Allergan
- Start
- Nov 2009
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of brimonidine in rhegmatogenous retinal detachment (RRD), sponsored by Allergan. Started Nov 2009; status: completed.
02
Drugs
brimonidine
03
Conditions
rhegmatogenous retinal detachment (RRD)
Beyond the preview
Go deeper on NCT00972374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00972374.